Tag Archives: stroke

TAVI-proteccion-cerebral-europcr 2018

EuroPCR 2018 | SENTINEL: Anatomical Predictors of Stroke during TAVR

EuroPCR 2018 | SENTINEL: Anatomical Predictors of Stroke during TAVR

The rate of cerebrovascular events in TAVR hovers about 4% in most of the current studies, regardless the center, the operator or the prosthetic valve. At present, no scores can adequately predict which patients run the highest risk of stroke during TAVR, and the routine use of cerebral protection devices remains controversial. The SENTINEL study


EuroPCR 2018 | Meta-Analyzis on Cerebral Protection Devices during TAVR

The risk of stroke is inherent to TAVR and, apart from clinically manifest events, there is abundant evidence of cerebral embolic lesions during TAVR provided by studies using diffusion weighted MRI or transcranial doppler ultrasound. Several devices have been developed to reduce the risk of stroke, though they have been assessed by relatively small trials

Stroke criptogénico y el fin de la controversia sobre el cierre del foramen oval

Stroke, Migraine and Patent Foramen Ovale Not Necessarily Temporary Associated

Cryptogenic stroke patients with migraine have high prevalence (79%) of patent foramen ovale (PFO) with right to left shunt. However, the timing of stroke in migraineurs is not usually associated to a migraine attack. These observations are consistent with the hypothesis that the most likely mechanism of stroke in these patients with migraine is a

ACC 2018 | Echocardiographic Data Help Better Choose Patients for Patent Foramen Ovale Closure

A new randomized controlled trial of patients who underwent patent foramen ovale (PFO) closure in cryptogenic stroke may provide certain morphological echocardiographic features that might allow us to better choose patients who would benefit more from PFO closure versus those for whom medical therapy would be more appropriate. Among patients with a recent cryptogenic stroke

Las nuevas guías de Hipertensión podrían estar a la altura de sus antecesoras

The new HTA guides 2017 could be up to their predecessors

From the first reports, back in 1920, we have studied, recognized and documented the excess of events associated with arterial hypertension. This linear relationship between the level of blood pressure and the risk of stroke, is evident in all adults beyond age, sex or race, transforming high blood pressure into the highest target of global

El desarrollo de las nuevas válvulas disminuye la necesidad de marcapaso

Development of New Valves Lowers Need for Pacemaker

Courtesy of Dr. Carlos Fava. While the benefits of TAVR are well-known, the need for a permanent pacemaker after implantation is still an issue to solve, even though new valves have reduced it. This study enrolled 175 patients who underwent TAVR with an ACURATE neo TF valve. In this population, 58% of patients were women and the

Importante estudio demuestra que debemos ocuparnos de la función renal en el TAVI

An Important Study Shows That Renal Function Must Be Cared for in TAVR

Courtesy of Dr. Carlos Fava. The presence of renal dysfunction in the “real world” is over 25% in patients who undergo transcatheter aortic valve implantation (TAVI). The evolution of this disease among patients who are subjected to a replacement is well known, but evidence for patients who undergo TAVI is still limited, particularly for those who

¿Fin de la discusión sobre el impacto del marcapaso post TAVI?

End of Discussion on the Impact of Pacemaker After TAVR?

Transcatheter aortic valve replacement (TAVR) is often associated with conduction abnormalities, which usually end with permanent pacemaker (PPM) implantation in 10-40% of patients. Factors predisposing to PPM after TAVR have been studied in great detail, but their short- and long-term clinical impact is still controversial.   Recently, outcomes from a large cohort of patients were

Enfermedad carotidea asintomática: ¿Endarterectomía o angioplastia?

Endarterectomy vs. Stenting in Asymptomatic Carotid Artery Stenosis

The comparative efficacy and safety of carotid stenting vs. endarterectomy in asymptomatic carotid stenosis patients remains controversial and, what is worse, consensus seems unlikely in the near future. Given the lack of definite evidence, several meta-analyzis and systematic reviews have been produced in an attempt to shed some light on this matter. This study included all

Es un hecho: la protección cerebral en TAVI logró demostrar que reduce el stroke y la muerte

It Is a Fact: Cerebral Protection in TAVR Has Proved to Reduce Stroke and Death

Cerebral ischemic events after transcatheter aortic valve replacement (TAVR) have been identified as independent predictors of morbidity and mortality. New-generation devices have managed to partially reduce the rate of cerebral events, but it still is around 5.5% at 30 days for patients undergoing TAVR through transfemoral access. First data on cerebral protection devices had only shown